Condition (MeSH)
Hantavirus Pulmonary Syndrome
ClinicalTrials.gov lists 5 trials for Hantavirus Pulmonary Syndrome or a narrower condition beneath it. National Institute of Allergy and Infectious Diseases (NIAID) has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Hantavirus Pulmonary Syndrome itself; the rest are tagged with a narrower condition beneath it.
When did Hantavirus Pulmonary Syndrome trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2
- Not applicable
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 1 |
| 2019 | 1 |
| 2003 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 5 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Hantavirus Pulmonary Syndrome trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Not applicable | 2 |
| Observational | 1 |
How many Hantavirus Pulmonary Syndrome trials are recruiting? (3)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
| Completed | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Hantavirus Pulmonary Syndrome trials? (1)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
Which serious adverse events do Hantavirus Pulmonary Syndrome trials report? (8)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Cardiac disorder | 26 | 1 |
| Hepatobiliary disorders | 26 | 1 |
| Respiratory, thoracic and mediastinal disorders | 7 | 1 |
| Renal and urinary disorders | 4 | 1 |
| Metabolism and nutrition disorders | 3 | 1 |
Showing 5 of 8 adverse events.
Which publications cover Hantavirus Pulmonary Syndrome? (3)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Safety and Immunogenicity of an Andes Virus DNA Vaccine by Needle-Free Injection: A Randomized, Controlled Phase 1 Study. | The Journal of infectious diseases | 2024 | Yes |
| Hantavirus Infection Is Inhibited by Griffithsin in Cell Culture. | Frontiers in cellular and infection microbiology | 2020 | Yes |
| High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2013 | Yes |
Rare-disease identity (2)
Shown in this order: exact, broader, narrower, other.
| Orphanet disease | ORPHA code | Relation | Source |
|---|---|---|---|
| Hantavirus pulmonary syndrome | 319247 | Exact | Orphadata Science knowledge files, Product 1 |
| Hantavirus pulmonary syndrome | 319247 | Exact | Orphanet Rare Disease Ontology (ORDO) |
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.